SCHEMBL7364259

SCHEMBL7364259

CC(N)N1Cc2ccccc2S1(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CACNA1H O95180 3/20 0.41
▸ KCNH2 Q12809 3/20 0.40
▸ FFAR4 Q5NUL3 7/20 0.40
▸ FFAR1 O14842 5/20 0.40
▸ PER2 O15055 1/20 0.40
▸ CRY1 Q16526 1/20 0.40
▸ CRY2 Q49AN0 1/20 0.40
▸ DPP8 Q6V1X1 2/20 0.36
▸ DPP9 Q86TI2 2/20 0.36
▸ DPP7 Q9UHL4 2/20 0.36
▸ DPP4 P27487 1/20 0.36
▸ MMP2 P08253 1/20 0.36
▸ MMP9 P14780 1/20 0.36
▸ ADAM17 P78536 1/20 0.36
▸ RECQL P46063 1/20 0.35
▸ HRH3 Q9Y5N1 1/20 0.35
▸ RAB9A P51151 1/20 0.34
▸ BRD4 O60885 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9255195 0.85 CACNA1H (0.43) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL8157650 0.73 BRD4 (0.50) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL19673967 0.73 FFAR4 (0.44) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL9754343 0.73 CACNA1H (0.47) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL7850153 0.72 ATM (0.57) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL3587960 0.70 FFAR4 (0.42) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL8242189 0.70 PER2 (0.51) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL28194834 0.69 FFAR4 (0.44) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL28207011 0.69 FFAR4 (0.44) CACNA1HKCNH2FFAR4FFAR1PER2
SCHEMBL10278293 0.69 PER2 (0.50) CACNA1HKCNH2FFAR4FFAR1PER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1175419-A2 ARYL SULFONYLS AS FACTOR XA INHIBITORS Du Pont Pharmaceuticals Company (US) 2002-01-30 — — EP disclosed
WO-2000059902-A2 ARYL SULFONYLS AS FACTOR XA INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 2000-10-12 — — WO disclosed
Send feedback